September 12 (SeeNews) - Bulgaria drug maker Tchaikapharma [BUL:7TH] said on Wednesday that it has successfully completed the clinical trials of four new dual-component fixed-dose pharmaceutical products for the treatment of arterial hypertension and other cardiovascular diseases.